Our equity analysts have no choice but to rate the stock NEUTRAL, despite David Knott’s ... reveal that 175 hedge …
We still like this stock. Even though this is a micro cap stock, Tom Steyer’s Farallon own more than 4 million shares or around 18% of the company. Ligand Pharma (LGND): There were several insider purchases after the company …
Geneva Advisors Ltd Limited Liability Company invested in 14,947 shares or 0.03% of the stock. Since February 27, 2017, it had 0 buys, and 7 insider sales for $11.11 million activity. $428,240 worth of Ligand Pharmaceuticals Inc. …
LGND LOSS ALERT: Rosen Law Firm Reminds Ligand Pharmace ... and other legal related news to the stock/financial …
LGND)'s short sellers to cover LGND's short positions. Its last month's stock price volatility remained 0.8% which for the week stands at 1.25%. About 75,371 shares traded. It has underperformed by 16.70% the S&P500. Since November …
Investors who purchased shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) have certain options and for certain …
The good news is that insiders at Ligand Pharmaceuticals (LGND) remain adamant that their stock is an excellent buy around the $10-$11 area. The bad news is that LGND is once again at that price after losing 30% of its value since last …
Ligand Pharmaceuticals (Nasdaq:LGND) hit a new 52-week high Monday as it is currently trading at $18.50, above its previous 52-week high of $18.22 with 7,059 shares traded as of 9:35 a.m. ET. Average volume has been 145,900 shares …
08/10 $GBDC Stock Quote Alert for Golub Capital BDC Inc. (NASDAQ:GBDC) From our Sto.. 08/09 $GBDC Stock
What follows is a stock analysis showing a specific look at how Ligand Pharmaceuticals Inc (LGND) fares in the ModernGraham valuation model. Company Profile (obtained from Google Finance): Ligand Pharmaceuticals …